On Oct 26, 2021 Ultimovacs closed a Post-IPO Equity round and raised NOK270,000,000 from investors, featuring lead investors .
About the company: Ultimovacs is located at Norway, Europe.
“Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. We enable the immune system to fight cancer”
Company website: http://www.ultimovacs.com